Vision Financial Markets LLC Acquires Shares of 15,800 CME Group Inc. (NASDAQ:CME)

Vision Financial Markets LLC acquired a new stake in CME Group Inc. (NASDAQ:CMEFree Report) during the 4th quarter, Holdings Channel reports. The institutional investor acquired 15,800 shares of the financial services provider’s stock, valued at approximately $3,669,000. CME Group makes up 3.9% of Vision Financial Markets LLC’s investment portfolio, making the stock its 8th biggest position.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Truvestments Capital LLC bought a new position in shares of CME Group during the third quarter worth approximately $26,000. SJS Investment Consulting Inc. increased its stake in shares of CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares during the period. Dunhill Financial LLC increased its stake in shares of CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 81 shares during the period. Financial Life Planners bought a new position in shares of CME Group during the fourth quarter worth approximately $32,000. Finally, Fortitude Family Office LLC increased its stake in shares of CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 83 shares during the period. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 1.0 %

Shares of CME opened at $254.48 on Thursday. The stock has a market capitalization of $91.70 billion, a price-to-earnings ratio of 26.32, a PEG ratio of 6.76 and a beta of 0.57. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $258.78. The stock has a fifty day moving average of $239.35 and a 200-day moving average of $230.06.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. As a group, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be given a $1.25 dividend. The ex-dividend date is Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a dividend yield of 1.96%. CME Group’s dividend payout ratio (DPR) is 51.71%.

CME Group announced that its Board of Directors has approved a stock buyback plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the company. JPMorgan Chase & Co. increased their price target on CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a research report on Thursday, February 13th. Deutsche Bank Aktiengesellschaft reduced their price target on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Keefe, Bruyette & Woods increased their price target on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research report on Friday, February 14th. Piper Sandler increased their price target on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Finally, Barclays increased their price target on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $236.13.

Get Our Latest Analysis on CME

Insider Transactions at CME Group

In other news, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the completion of the transaction, the insider now directly owns 27,046 shares of the company’s stock, valued at approximately $6,774,211.62. This trade represents a 12.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Suzanne Sprague sold 1,500 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the completion of the sale, the chief operating officer now owns 8,036 shares of the company’s stock, valued at approximately $2,063,885.88. This represents a 15.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,076 shares of company stock valued at $4,271,496. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.